CD40-ligated dendritic cells effectively expand melanoma-specific CD8+ CTLs and CD4+ IFN-γ-producing T cells from tumor-infiltrating lymphocytes

Journal of Immunology

Volumn 164, Issue 12, 2000, Pages 6633-6639

  Terheyden, Patrick ^a   Thor Straten, Per ^b   Bröcker, Eva B ^a   Kämpgen, Eckhart ^a   Becker, Jürgen C ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; GAMMA INTERFERON;

ARTICLE; CANCER IMMUNOLOGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; MELANOMA; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; TUMOR ASSOCIATED LEUKOCYTE;

ANTIGENS, CD40; CD40 LIGAND; CELL DIVISION; CLONE CELLS; DENDRITIC CELLS; EPITOPES, T-LYMPHOCYTE; HUMANS; IMMUNOPHENOTYPING; INTERFERON TYPE II; LIGANDS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; MELANOMA; MEMBRANE GLYCOPROTEINS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS; TH2 CELLS; TUMOR CELLS, CULTURED;

EID: 0342647340     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
2. McLellan, A. D., G. C. Starling, L. A. Williams, B. D. Hock, and D. N. Hart. 1995. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule. Eur. J. Immunol. 25:2064.
3. Caux, C., C. Massacrier, B. Vanbervliet, B. Dubois, C. van Koten, I. Durand, and J. Banchereau. 1994. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180:1263.
4. McLellan, A. D., R. V. Sorg, L. A. Williams, and D. N. Hart. 1996. Human dendritic cells activate T lymphocytes via a CD40: CD40 ligand-dependent pathway. Eur. J. Immunol. 26:1204.
5. Peguet-Navarro, J., C. Dalbiez-Gauthier, F.-M. Rattis, C. van Kooten, J. Banchereau, and D. Schmitt. 1995. Functional expression of CD40 antigen on human epidermal Langerhans cells. J. Immunol. 155:4241.
6. Koch, F., U. Stanzyl, P. Jennewein, K. Janke, C. Heufler, E. Kämpgen, N. Romani, and G. Schuler. 1996. High level IL12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL4 and IL40. J. Exp. Med. 184:741.
7. Campbell, K. A., P. J. Ovendale, M. K. Kennedy, W. C. Fanslow, S. G. Reed, and C. R. Maliszewski. 1996. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4:283.
8. + T cells. J. Immunol. 154:5071.
9. + T-helper and a T-killer cell. Nature 393: 474.
10. Benett, S. R., F. R. Carbone, F. Karamalis, R. A. Flavell, J. F. Miller, and W. R. Heath. 1998. Help for cytotoxic T-cell responses is mediated by CD40 signalling. Nature 393:478.
11. Schoenberger, S. P., R. E. Toes, V. E. van der, R. Offringa, and C. J. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated via CD40-CD40L interactions. Nature 393:480.
12. Mackey, M. F., J. R. Gunn, C. Maliszewski, H. Kikutani, R. F. Noelle, and R. J. Barth. 1998. Dendritic cells require maturation via CD40 to generate protective antitumor immunity. J. Immunol. 161:2094.
13. Abbas, A. K., K. M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383:787.
14. + T helper cell phenotype development in a T cell receptor-αβ transgenic model. J. Exp. Med. 182:1579.
15. Freeman, G. J., V. A. Boussiotis, A. Anumanthan, G. M. Bernstein, X. Y. Ke, P. D. Rennert, G. S. Gray, J. G. Gribben, and L. M. Nadler. 1995. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2:523.
16. Pulendran, B., J. L. Smith. G. Caspary, K. Brasel, D. Pettit, E. Maraskovski, and C. R. Maliszewski. 1999. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. USA 96:1036.
17. Rissoan, M.-C., V. Soumelis, N. Kadowaki, G. Grouard, F. Briere, R. de Waal Malefyt, and Y.-J. Liu. 1999. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283: 1183.
18. Cella, M., D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, and G. Alber. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184:747.
19. Snijders, A., P. Kalinski, C. M. Hilkens, and M. L. Kapsenberg. 1998. High-level IL-12 production by human dendritic cells requires two signals. Int. Immunol. 10:1593.
20. Becker, J. C., T. Brabletz, T. Kirchner, C. T. Conrad, E.-B. Bröcker, and R. A. Reisfeld. 1995. Negative transcriptional regulation in anergic T cells. Proc. Natl. Acad. Sci. USA 92:2375.
21. Boon, T., and P. van der Bruggen. 1996. Human tumor-antigens recognized by T lymphocytes. J Exp. Med. 183:725.
22. Romani, N., D. Reider, M. Heuer, S. Ebner, E. Kämpgen, B. Eibl, D. Niederwieser, and G. Schuler. 1996. Generation of mature dendritic cells from human blood: an improved method with special regard to clinical applicability. J. Immunol. Methods 196:137.
23. Grabbe, S., S. Brunvers, R. L. Gallo, T. L. Knisely, R. Nazareno, and R. D. Granstein. 1991. Tumor antigen presentation by murine epidermal cells. J. Immunol. 146:3656.
24. Jonuleit, H., U. Kuhn, G. Muller, K. Steinbrink, L. Paragnik, E. Schmitt, J. Knop, and A. H. Enk. 1997. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 27:3135.
25. thor-Straten. P., J. C. Becker, T. Seremet, E. B. Bröcker, and J. Zeuthen. 1996. Clonal T cell responses in tumor infiltrating lymphocytes from both regressive and progressive regions of primary human malignant melanoma. J. Clin. Invest. 97:279.
26. Bröcker, E.-B., K. M. Kuhlencordt, and W. Müller-Ruchholtz. 1977. Microcytotoxicity test in allograft immunity. Int. Arch Allergy Appl. Immunol. 53:234.
27. Grewal, I. S., J. Xu, and R. A. Flavell. 1995. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378:617.
28. + CTL responses. J. Exp. Med. 183: 2129.
29. van Essen, D., H. Kikutani, and D. Gray. 1995. CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 378:620.
30. + cylotoxic T lymphocytes from human naive precursors: helper effect requirement for efficient primary cytotoxic T lymphocyte induction in vitro. Int. J. Cancer 72:987.
31. + lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptide. Crit. Rev. Immunol. 18:87.
32. Armitage, R. J., T. W. Tough, B M. Macduff, W. C. Fanslow, M. K. Spriggs, F. Ramsdell, and M. R. Alderson. 1993. CD40 ligand is a T cell growth factor. Eur. J. Immunol. 23:2326.
33. Yang, S., T. L. Darrow, C. E. Vervaert, and H. F. Seigler. 1997. Immunotherapeutic potential of tumor antigen-pulsed and unpulsed dendritic cells generated from murine bone marrow. Cell. Immunol. 179:84.
34. Zitvogel, L., J. I. Mayordomo, T. Tjandrawan, A. B. De Leo, M. R. Clark, M. T. Lotze, and W. J. Storkus. 1996. Therapy of murine tumors with tumor-peptide pulsed DC: dependence on T-cells, B7 costimulation, and Th1-associated cytokines. J. Exp. Med. 183:87.
35. Nestle, F. O., S. Alijagic, M. Gilliet, Y. Sun, S. Grabbe, R. Dummer, G. Burg, and D. Schadendorf. 1998. Vaccination of melanoma patients with peptide-or tumor lysate pulsed dendritic cells. Nat. Med. 4:328.
36. Wagner, S. N., T. Schultewolter, C. Wagner, L. Briedrigkeit, J. C. Becker, H. M. Kwasnicka, and M. Goos. 1998. Immune response against human primary malignant melanoma: a distinct cytokine mRNA profile associated with spontaneous regression. Lab. Invest. 78:541.
37. Lowes, M. A., G. A. Bishop, K. Crotty, R. S. Barnetson, and G. M. Halliday. 1997. T helper 1 cytokine mRNA is increased in spontaneously regressing primary melanomas. J. Invest. Dermatol. 108:914.
38. + cytotoxic T-lymphocyte activation in mice. Cancer Res. 56:5005.
39. Fearon, D. T., and R. M. Locksley. 1996. The instructive role of innate immunity in the aquired immune response. Science 272:50.
40. Zorn, E., and T. Hercend. 1999. A natural cytotoxic T cell response in a spontaneously regressing human melanoma targets a neoantigen resulting from a somatic point mutation. Eur. J. Immunol. 29:592.